195 related articles for article (PubMed ID: 9704450)
1. Modified hemoglobin-based blood substitutes: crosslinked, recombinant and encapsulated hemoglobin.
Chang TM
Vox Sang; 1998; 74 Suppl 2():233-41. PubMed ID: 9704450
[TBL] [Abstract][Full Text] [Related]
2. Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties.
D'Agnillo F; Chang TM
Nat Biotechnol; 1998 Jul; 16(7):667-71. PubMed ID: 9661202
[TBL] [Abstract][Full Text] [Related]
3. Two future generations of blood substitutes based on polyhemoglobin-SOD-catalase and nanoencapsulation.
Chang TM; D'Agnillo F; Yu WP; Razack S
Adv Drug Deliv Rev; 2000 Feb; 40(3):213-8. PubMed ID: 10837791
[TBL] [Abstract][Full Text] [Related]
4. Nanobiotechnological modification of hemoglobin and enzymes from this laboratory.
Chang TM
Biochim Biophys Acta; 2008 Oct; 1784(10):1435-40. PubMed ID: 18565337
[TBL] [Abstract][Full Text] [Related]
5. Future generations of red blood cell substitutes.
Chang TM
J Intern Med; 2003 May; 253(5):527-35. PubMed ID: 12702030
[TBL] [Abstract][Full Text] [Related]
6. Crosslinked hemoglobin-superoxide dismutase-catalase scavenges free radicals in a rat model of intestinal ischemia-reperfusion injury.
Razack S; D'Agnillo F; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1997; 25(1-2):181-92. PubMed ID: 9083638
[TBL] [Abstract][Full Text] [Related]
7. Reduction of hydroxyl radical generation in a rat hindlimb model of ischemia-reperfusion injury using crosslinked hemoglobin-superoxide dismutase-catalase.
D'Agnillo F; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1997; 25(1-2):163-80. PubMed ID: 9083637
[TBL] [Abstract][Full Text] [Related]
8. [Hemoglobin-based oxygen carriers and trials to substitute red blood cells].
Smani Y; Labrude P; Vigneron C; Faivre B
Transfus Clin Biol; 2007 Nov; 14(5):464-73. PubMed ID: 18295525
[TBL] [Abstract][Full Text] [Related]
9. Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant.
Bian Y; Rong Z; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 2011 Jun; 39(3):127-36. PubMed ID: 21574914
[TBL] [Abstract][Full Text] [Related]
10. Absence of hemoprotein-associated free radical events following oxidant challenge of crosslinked hemoglobin-superoxide dismutase catalase.
D'Agnillo F; Chang TM
Free Radic Biol Med; 1998 Apr; 24(6):906-12. PubMed ID: 9607600
[TBL] [Abstract][Full Text] [Related]
11. Blood substitutes based on modified hemoglobin prepared by encapsulation or crosslinking: an overview.
Chang TM
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):159-79. PubMed ID: 1391433
[TBL] [Abstract][Full Text] [Related]
12. Cross-linked polyhemoglobin-superoxide dismutase-catalase supplies oxygen without causing blood-brain barrier disruption or brain edema in a rat model of transient global brain ischemia-reperfusion.
Powanda DD; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 2002 Jan; 30(1):23-37. PubMed ID: 12000224
[TBL] [Abstract][Full Text] [Related]
13. Future prospects for artificial blood.
Chang TM
Trends Biotechnol; 1999 Feb; 17(2):61-7. PubMed ID: 10087605
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic protection from autoxidation for crosslinked hemoglobins.
Yang T; Olsen KW
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):709-17. PubMed ID: 7994392
[TBL] [Abstract][Full Text] [Related]
15. Temperature stability of Poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] in the form of a solution or in the lyophilized form during storage at -80 °C, 4 °C, 25 °C and 37 °C or pasteurization at 70 °C.
Bian YZ; Guo C; Chang TM
Artif Cells Nanomed Biotechnol; 2016; 44(1):41-7. PubMed ID: 26613265
[TBL] [Abstract][Full Text] [Related]
16. Cross-linked hemoglobins being well into clinical trials, increasing research efforts are now on a second generation red blood cell substitute based on encapsulated hemoglobin.
Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):257-62. PubMed ID: 7493046
[No Abstract] [Full Text] [Related]
17. Oxygen carriers.
Chang TM
Curr Opin Investig Drugs; 2002 Aug; 3(8):1187-90. PubMed ID: 12211412
[TBL] [Abstract][Full Text] [Related]
18. Modified hemoglobin blood substitutes: present status and future perspectives.
Chang TM
Biotechnol Annu Rev; 1998; 4():75-112. PubMed ID: 9890139
[TBL] [Abstract][Full Text] [Related]
19. Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant.
Bian Y; Rong Z; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 2012 Feb; 40(1-2):28-37. PubMed ID: 21689051
[TBL] [Abstract][Full Text] [Related]
20. Hemoglobin-based red blood cell substitutes.
Chang TM
Artif Organs; 2004 Sep; 28(9):789-94. PubMed ID: 15320941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
